CollPlant Biotechnologies (CLGN) Finished Goods (2022 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Finished Goods came in at $290000.0 in Q4 2025, up 88.31% YoY from $154000.0 in Q4 2024, and down 41.3% on a QoQ basis from $494000.0 in Q2 2025.
CollPlant Biotechnologies (CLGN) Finished Goods (2022 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 4 years of Finished Goods data on file, last reported at $290000.0 in Q4 2025.
- Quarterly Finished Goods rose 88.31% year-over-year to $290000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $290000.0 (up 88.31% YoY) and the FY2025 annual result came in at $290000.0, up 88.31% from the prior year.
- Finished Goods slipped to $290000.0 in Q4 2025, from $494000.0 in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $549000.0 in Q4 2022 to a low of $154000.0 in Q4 2024.
- A 4-year average of $374833.3 and a median of $392000.0 in 2025 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2024 — Finished Goods slumped 71.53% — and 2025, when it jumped 123.53%.
- Tracing CLGN's Finished Goods over 4 years: stood at $549000.0 in 2022, then decreased by 1.46% to $541000.0 in 2023, then tumbled by 71.53% to $154000.0 in 2024, then soared by 88.31% to $290000.0 in 2025.
- The last three Finished Goods figures came in at $290000.0 (Q4 2025), $494000.0 (Q2 2025), and $154000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | CollPlant Biotechnologies | 4.13 Mn | 4.13 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 290,000.00 |
| Jun 30, 2025 | 494,000.00 |
| Dec 31, 2024 | 154,000.00 |
| Jun 30, 2024 | 221,000.00 |
| Dec 31, 2023 | 541,000.00 |
| Dec 31, 2022 | 549,000.00 |